Divergent roles of serum CXCL9 as a biomarker in ILD and COPD: a comparative study
Key Points
CXCL9 levels correlate with divergent roles in ILD and COPD, revealing distinct biomarker functions.
As a prognostic marker, CXCL9 may identify treatable inflammation in ILD while reflecting the inflammatory burden in COPD.
Observational analysis of serum CXCL9 levels demonstrates its significance in inflammatory conditions related to lung diseases.
These findings suggest that CXCL9 could guide treatment strategies based on its specific role in each condition.
Abstract
CXCL9 levels correlate with divergent roles in ILD and COPD. It may serve as a prognostic marker, identifying treatable inflammation in ILD and inflammatory burden in COPD.